Camille Nelson Kotton MD, FIDSA, FAST is the clinical director of the Transplant Infectious Disease and Immunocompromised Host Program at the Massachusetts General Hospital, and Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts. She was chair of The Infectious Disease Community of Practice of The American Society of Transplantation (2012-2018). From 2007-2013, she was the president of The Transplant Infectious Disease Section of The Transplantation Society. Highlights of her time as president include the development of international guidelines on CMV management after solid organ transplant, published in Transplantation (2010, 2013, 2018). She is the first transplant infectious disease specialist to be a councilor of The Transplantation Society (2020). Dr. Kotton has authored the past three versions of the American Society of Transplantation Travel Medicine guidelines, and has been an author of the CDC Yellow Book Chapter on Immunocompromised Hosts and Travel for the past decade. Her clinical interests include vaccinations in transplant candidates and recipients, cytomegalovirus, zoonoses, and travel and tropical medicine in the transplant setting. She is a member of the CDC Advisory Committee on Immunization Practices (ACIP) and is involved in national decisions regarding COVID-19 vaccines.
